An Update from the Ribavirin Pregnancy Registry after Nine Years of Enrollment

被引:0
|
作者
Roberts, Susan Sinclair [1 ,2 ]
Jones, Judith K. [3 ]
Miller, Richard K. [4 ]
Kwo, Paul Y. [5 ]
Greene, Micheal F. [6 ]
Thorpe, Phoebe G. [7 ]
Maddrey, Willis C. [8 ]
机构
[1] Univ N Carolina, Clin Res Program, Wilmington, NC 28401 USA
[2] INC Res, Post Approval & Strateg Serv, Wilmington, NC USA
[3] Degge Grp, Alexandria, VA USA
[4] Univ Rochester, Med Ctr, Rochester, NY 14642 USA
[5] Indiana Univ, Sch Med, Indianapolis, IN USA
[6] Harvard Univ, Sch Med, Boston, MA USA
[7] Ctr Dis Control & Prevent, Div Birth Defect & Dev Disabil, Atlanta, GA USA
[8] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
LB30
引用
收藏
页码:1394A / 1395A
页数:2
相关论文
共 50 条
  • [11] Update from the north American pregnancy registry
    Holmes, LB
    Wyszynski, DF
    Baldwin, E
    Smith, CRR
    EPILEPSIA, 2005, 46 : 40 - 40
  • [12] EXPECT Enrollment: Impact of Recruitment Strategy on Enrollment in the Xolair® Pregnancy Registry
    Covington, Deborah
    Wang, Vivian
    Carrigan, Gillis
    Hurst, Nicole
    Veith, Joachim
    Chen, Hubert
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 148 - 149
  • [13] Final results from the ribavirin pregnancy registry, 2004-2020
    Sinclair, Susan M.
    Jones, Judith K.
    Miller, Richard K.
    Greene, Michael F.
    Kwo, Paul Y.
    Maddrey, Willis C.
    BIRTH DEFECTS RESEARCH, 2022, 114 (20): : 1376 - 1391
  • [14] The Ribavirin Pregnancy Registry: Challenges and Lessons Learned
    Roberts, S. S.
    Jones, J. K.
    Miller, R. K.
    Lau, L. F.
    Kwo, P. Y.
    Greene, M. F.
    Necsoi, D. R.
    Robertson, C. S.
    Maddrey, W. C.
    DRUG SAFETY, 2012, 35 (10) : 914 - 915
  • [15] Improving accuracy for prospective pregnancy registry enrollment targets
    Veley, Kristin
    Covington, Deborah
    Pozin, Payal
    Buus, Rebecca Morris
    Okala, Sandra
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 250 - 251
  • [16] Recruitment Efforts and Enrollment into the OTIS Actemra Pregnancy Registry
    Chambers, C. D.
    Johnson, D. L.
    Miller, K.
    Bezchinsky, M.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2012, 94 (05) : 366 - 366
  • [17] Update from the United States Zika Pregnancy and Infant Registry
    Baez-Santiago, M. A.
    Carr, C.
    Ellington, S.
    Jones, A. M.
    Fulton, A.
    Reynolds, M.
    Gilboa, S. M.
    Honein, M. A.
    BIRTH DEFECTS RESEARCH, 2018, 110 (09): : 748 - 748
  • [18] Swiss Neuroendocrine Tumor (SwissNET) Registry: Update After Three Years
    Stettler, C.
    Limacher, A.
    Christ, E.
    Wagner, S.
    Pralong, F.
    Forrer, F.
    Clerici, T.
    Kolb, W.
    Triponez, F.
    Perren, A.
    NEUROENDOCRINOLOGY, 2012, 96 : 63 - 63
  • [19] Progress Towards Enrollment in a US Pregnancy Registry for Galcanezumab and Lasmiditan
    Ephross, Sara A.
    Stone, Stacey
    Hill, Amelia
    Ruff, Dustin
    Adaji, Enemona Emmanuel
    Le Noan-Laine, Maryline
    Schroeder, Krista M.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 666 - 666
  • [20] The Savella® (Milnacipran) Pregnancy Registry: Interim Analysis and Enrollment Challenges
    Hirsch, D. K.
    Roberts, Sinclair S.
    Brown, V. D.
    Palmer, R.
    McLean, J.
    Leclair, D.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2013, 97 (05) : 299 - 299